The Detection Of Circulating Tumor Cells (CTC) In Patients With Non-small Cell Lung Cancer (NSCLC) Undergoing Definitive Radiotherapy Or Chemoradiotherapy



Status:Recruiting
Conditions:Lung Cancer, Lung Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:7/20/2017
Start Date:September 2012
Contact:Samuel Swisher McClure, MD
Email:PennCancerTrials@emergingmed.com
Phone:855-216-0098

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria
Patients with NSCLC who undergo radiation as part of a definitive course of treatment will be
enrolled. Blood collections will be obtained before, during, and after radiotherapy. We will
collect demographic and treatment data and explore & describe the pattern of CTC detection in
all patients


Inclusion Criteria:

- Patients with biopsy-proven NSCLC who are undergoing definitive radiotherapy as a part
of their treatment regimen.

- Age 18 or older

- Signed informed consent

- Patients who are incapable of providing informed consent are excluded from
participating in this study.
We found this trial at
1
site
Abramson Cancer Center of the University of Pennsylvania
3400 Civic Center Blvd
Philadelphia, Pennsylvania 19104
(215) 662-6065
Principal Investigator: Samuel Swisher McClure, MD
Phone: 855-216-0098
Abramson Cancer Center of the University of Pennsylvania The Abramson Cancer Center of the University...
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials